REESTEEME – BIOREGENERATIVE INJECTABLE TREATMENT

Retix.C – Resteeme is an advanced bioregenerative injectable concept designed to restore skin structure and function.

The treatment goes beyond traditional biostimulation by activating ECM remodeling at a tissue level.

It is based on a patented non-crosslinked hyaluronic acid complex:

* LMW (200–400 kDa) – cellular signaling
* MMW (1000–1500 kDa) – tissue balance
* HMW (1800–2600 kDa) – structural support

This synergy enables effective tissue regeneration.

Trehalose protects cells from oxidative stress and glycation.

Resteeme also targets chronic low-grade inflammation (inflammaging).

⸻

REESTEEME X / L / H

X – Extended Bioregeneration
LMW + MMW + trehalose, 25 mg/ml
Stimulates fibroblasts and collagen production

L – Bioregeneration & Lifting
HMW HA, 20 mg/ml
Improves structure and firmness

H – Biorevitalisation & Hydration
MMW HA, 20 mg/ml
Enhances hydration and skin quality

⸻

COMBINATION TREATMENTS

Resteeme can be combined with:

* fractional lasers
* RF microneedling
* IPL
* URGO R.PEN

and professional Retix.C treatments:

* retinol treatments
* vitamin C treatments
* barrier repair protocols
* pigmentation treatments

⸻

LAUNCH

Launching August–September
info@royalcosmed.com